References
ACSL (1991) Advanced continuous simulation language. Mitchell and Gauthier Associates, Concord, MA
Bolt H, Filser J, Stormer F (1984) Inhalation pharmacokinetics based on gas uptake studies, V. comparative pharmacokinetics of ethylene and 1,3-butadiene in rats. Arch Toxicol 55:213–218
Cote IL, Bayard SP (1990) Cancer risk assessment of 1,2-butadiene. Environ Hlth Perspect 86:149–153
Hallenbeck WH (1990) Cancer risk assessment for the inhalation of 1,3-butadiene. Environ Professional 12:286–290
Hallenbeck WH, Cunningham KM (1986) Quantitative risk assessment for environmental and occupational health. Lewis Pub., Chelsea, MI
Keller1991 DuPont Laboratories, Delaware
Melnick RL, Huff JE, Haseman JK, McConnell EE (1988) Chronic toxicity results and ongoing studies of 1,3-butadiene by the NTP. Ann NY Acad Sci 534:648–62
Morrow NL (1990) The industrial production and use of 1,3-butadiene. Environ Hlth Perspect 86:7–8
OSHA (1990) Occupational exposure to 1,3-butadiene. Fed Reg 55:32736–32826
Ramsey JC, Anderson ME (1984) A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 73:159–175
Presperin CA (1991) Cancer risk assessment for 1,3-butadiene by physiological pharmacokinetic and non-physiological methods. MS thesis, University of Illinois at Chicago
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hallenbeck, W.H. Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modeling. Bull. Environ. Contam. Toxicol. 49, 66–70 (1992). https://doi.org/10.1007/BF00193342
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00193342